Caspase activation by anticancer drugs: The caspase storm

Molecular Pharmaceutics

Volumn 4, Issue 4, 2007, Pages 583-595

  Tao, Zhimin ^a   Goodisman, Jerry ^a   Penefsky, Harvey S ^b   Souid, A K ^c  

^a SYRACUSE UNIVERSITY   (United States)

^b PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^c State University of New York Upstate Medical University: College of Medicine   (United States)

Author keywords

Apoptosis; Carboplatin; Caspase; Cisplatin; Dactinomycin; Doxorubicin; Fluorogenic

Indexed keywords

7 AMINO 4 TRIFLUOROMETHYL COUMARIN; ANTINEOPLASTIC AGENT; BENZYLOXYCARBONYLVALYLALANYLASPARTYLFLUOROMETHYLKETONE; CARBOPLATIN; CASPASE; CISPLATIN; COUMARIN DERIVATIVE; DACTINOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING); DOXORUBICIN; KETONE DERIVATIVE; N ACETYLASPARTYLGLUTAMYLVALYLASPARTYL 7 AMINO 4 TRIFLUOROMETHYL COUMARIN; OXALIPLATIN; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CELL DISRUPTION; CELL RESPIRATION; CONTROLLED STUDY; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME SUBSTRATE; FLUORESCENCE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS; CARBOPLATIN; CASPASES; CELL RESPIRATION; CISPLATIN; COUMARINS; DACTINOMYCIN; DOXORUBICIN; ENZYME ACTIVATION; FLUORESCENT DYES; HL-60 CELLS; HUMANS; JURKAT CELLS; ORGANOPLATINUM COMPOUNDS; OXYGEN CONSUMPTION; SUBSTRATE SPECIFICITY; TIME FACTORS;

EID: 34548172792     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp070002r     Document Type: Article

References (47)

1. Hengartner, M. O. The biochemistry of apoptosis. Nature 2000, 407, 770-776.
2. Earnshaw, W. C.; Martins, L. M.; Kaufamnn, S. H. Mammalian caspases: structure, activation, substrate, and functions during apoptosis. Annu. Rev. Biochem. 1999, 68, 383-424.
3. Boatright, K. M.; Salvesen, G. S. Mechanism of caspase activation. Curr. Opin. Cell Biol. 2003, 15, 725-731.
4. Shiozaki, E. N.; Chai, J.; Rigotti, D. J.; Riedl, S. J.; Li, P.; Srinivasula, S. M.; Alnemri, E. S.; Fairman, R.; Shi, Y. Mechanism of XIAP-mediated inhibition of caspase-9. Mol. Cell 2003, 11, 519-27.
5. Green, D. R.; Kroemer, G. The pathophysiology of mitochondrial cell death. Science 2004, 305, 626-629.
6. Hao, Z.; Duncan, G. S.; Chang, C-C; Elia, A.; Fang, M.; Wakeham, A.; et al. Specific ablation of the apoptotic functions of cytochrome c reveals a differential requirement of cytochrome c and Apaf-1 in apoptosis. Cell 2005, 121, 579-591.
7. Slee, E. A.; Zhu, H.; Chow, S. C.; MacFarlane, M.; Nicholson, D. W.; Cohen, G. M. Benzylooxycarbonyl-Val-Ala-Asp (Ome) fluormethylketone (Z-VAD. FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem. J. 1996, 315, 21-24.
8. Waterhouse, N. J.; Sedelies, K. A.; Sutton, V. R.; Pinkoski, M. J.; Thia, K. Y.; Johnstone, R.; et al. Functional dissociation of Δψ and cytochrome c release defines the contribution of mitochondria upstream of caspase activation during granzyme B-induced apoptosis. Cell Death Differ. 2006, 13, 607-618.
9. Binaschi, M.; Bigioni, M.; Cipollone, A.; Rossi, C.; Goso, C.; Maggi, C. A.; et al. Anthracyclines: Selected new developments. Curr. Med. Chem. 2001, 1, 113-130.
10. Zunino, F.; Capranico, G. DNA topoisomerase II as the primary target of anti-tumor anthracyclines. Anticancer Drug Des. 1990, 5, 307-317.
11. Kostoryz, E. L.; Yourtee, D. M. Oxidative mutagenesis of doxorubicin-Fe(III) complex. Mutat. Res. 2001, 490, 131-139.
12. Bellarosa, D.; Ciucci, A.; Bullo, A.; Nardelli, F.; Manzini, S.; Maggi, C. A.; et al. Apoptotic events in a human ovarian cancer cell line exposed to anthracyclines. J. Pharmacol. Exp. Ther. 2001, 296, 276-283.
13. Speth, P. A.; Linssen, P. C.; Boezeman, J. B.; Wessels, H. M.; Haanen, C. Cellular and plasma adriamycin concentrations in long-term infusion therapy of leukemia patients. Cancer Chemother. Pharmacol. 1987, 20, 305-310.
14. Muller, W.; Crother, D. M. Studies of the binding of actinomycin and related compounds to DNA. J. Mol. Biol. 1968, 35, 251-290.
15. Veal, G. J.; Cole, M.; Errington, J.; Parry, A.; Hale, J.; Pearson, A. D. J.; et al. Pharmacokinetics of dactinomycin in a pediatric patient population: a United Kingdom Children's Cancer Study Group study. Clin. Cancer Res. 2005, 11, 5893-5899.
16. Tao, Z.; Withers, H. G.; Penefsky, H. S.; Goodisman, J.; Souid, A.-K. Inhibition of cellular respiration by doxorubicin. Chem. Res. Toxicol. 2006, 19, 1051-1058.
17. Tao, Z.; Ahmad, S. S.; Penefsky, H. S.; Goodisman, J.; Souid, A.-K. Dactinomycin Impairs Cellular Respiration and Reduces Accompanying ATP Formation. Mol. Pharmacol. 2006, 3, 762-772.
18. Harker, W. G.; Slade, D. L.; Drake, F. H.; Parr, R. L. Mitoxantrone resistance in HL-60 leukemia cells: Reduced nuclear topoisomerase II catalytic activity and drug-induced DNA cleavage in association with reduced expression of the topoisomerase II b isoform. Biochemistry 1991, 30, 9953-9961.
19. Dabrowiak, J. C.; Goodisman, J.; Souid, A.-K. Kinetic study of the reaction of cisplatin with thiols. Drug Metab. Dispos. 2002, 30, 1378-1384.
20. Hagrman, D.; Goodisman, J.; Dabrowiak, J. C.; Souid, A.-K. Kinetic study on the reaction of cisplatin with metallothionein. Drug Metab. Dispos. 2003, 31, 916-923.
21. Hagrman, D.; Goodisman, J.; Souid, A.-K. Kinetic study on the reaction of platinum drugs with glutathione. J. Pharmacol. Exp. Ther. 2004, 308, 658-666.
22. Tacka, K. A.; Szalda, D.; Souid, A.-K.; Goodisman, J.; Dabrowiak, J. C. Experimental and theoretical studies on the pharmacodynamics of cisplatin in Jurkat cells. Chem. Res. Toxicol. 2004, 17, 1434-1444.
23. Goodisman, J.; Hagrman, D.; Tacka, K. A.; Souid, A.-K. Analysis of cytotoxicities of platinum compounds. Cancer Chemother. Pharmacol. 2006, 57, 257-267.
24. Souid, A.-K.; Dubowy, R. L.; Blaney, S.; Hershon, L.; Sullivan, J.; McLeod, W.; et al. Phase I clinical and pharmacologic study of weekly cisplatin and irinotecan combined with amifostine for refractory solid tumors (Children Oncology Group trial 9970). Clin. Cancer Res. 2003, 9, 703-710.
25. Centerwall, C. R.; Goodisman, J.; Kerwood, D. J.; Dabrowiak, J. C. Cisplatin carbonato complexes: Implications for uptake, antitumor effects, and cytotoxicity. J. Am. Chem. Soc. 2005, 127, 12768-12769.
26. Di Pasqua, A. J.; Goodisman, J.; Kerwood, D. J.; Toms, B. B.; Dubowy, R. L.; Dabrowiak, J. C. Activation of carboplatin by carbonate. Chem. Res. Toxicol. 2006, 19, 139-149.
27. Tacka, K. A.; Dabrowiak, J. C.; Goodisman, J.; Penefsky, H. S.; Souid, A.-K. Effects of Cisplatin on mitochondrial function of Jurkat cells. Chem. Res. Toxicol. 2004, 17, 1102-1111.
28. Nicholson, D. W.; Thornberry, N. A. Caspases: killer proteases. Trends Biochem. Sci. 1997, 22, 299-306.
29. Gurtu, V.; Kain, S. R.; Zhang, G. Fluorometric and colorimetric detection of caspase activity associated with apoptosis. Anal. Biochem. 1997, 251, 98-102.
30. Martins, L. M.; Kottke, T.; Mesner, P. W.; Basi, G. S.; Sinha, S.; Frigon, N.; et al. Activation of multiple interleukin-1beta converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis. J. Biol. Chem. 1997, 272, 7421-7430.
31. Keppler-Hafkemeyer, A.; Brinkmann, U.; Pastan, I. Role of caspases in immunotoxin-induced apoptosis of cancer cells. Biochem. 1998, 37, 16934-16942.
32. Kim, W. H.; Yeo, M.; Kim, M. S.; Chun, S. B.; Shin, E. C.; Park, J. H.; Park, I. S. Role of caspase-3 in apoptosis of colon cancer cells induced by nonsteroidal anti-inflammatory drugs. Int. J. Colorectal Dis. 2000, 15, 112-113.
33. Mese, H.; Sasaki, A.; Nakayama, S.; Alcalde, R. E.; Matusumura, T. The role of caspase family protease, caspase-3 on cisplatin-induced apoptosis in cisplatin-resistant A431 cell line. Cancer Chemother. Pharmacol. 2000, 46, 241-245.
34. Xue, L.-Y; Chiu, S.-M.; Oleinick, N. L. Photodynamic therapy-induced death of MCF-7 human breast cancer cells: a role for caspase-3 in the late step of apoptosis but not for the critical lethal event. Exp. Cell Res. 2001, 263, 145-155.
35. Milner, A. E.; Palmer, D. H.; Hodgkin, E. A.; Eliopolous A. G.; Knox, P. G.; Poole, C. J.; Kerr, D. J.; Young, L. S. Induction of apoptosis by chemotherapeutic drugs: the role of FADD in activation of caspase-8 and synergy with death-receptor ligands in ovarian carcinoma cells. Cell Death Differ. 2002, 9, 287-300.
36. Waltereit, R.; Weller, M. The role of caspases 9 and 9-short (9S) in death ligand- and drug-induced apoptosis in human astrocytoma cells. Brain Res.: Mol. Brain Res. 2002, 106, 42-49.
37. Emanuele, S.; Calvaruso, G.; Lauricella, M.; Giuliano, M.; Bellavia, G.; D'Anneo, A.; Vento, R.; Tesoriere, G. Apoptosis induced in hepatoblastoma HepG2 cells by the proteosome inhibitor MG132 is associated with hydrogen peroxide production, expression of Bcl-XS and activation of caspase-3. Int. J. Oncol. 2002, 21, 857-865.
38. Zhang, B.; Zhang, Y.; Shacter, E. Caspase 3-mediated inactivation of Rac GTPases promotes drug-induced apoptosis in human lymphoma cells. Mol. Cell. Biol. 2003, 23, 5716-5725.
39. Zhao, X.; Tian, H.; Quan, P.; Liu, S. Corrrelation between drug resistance of leukemic cells and caspase-3. Xi'an Jiaotong Daxue Xuebao, Yixueban 2005, 26, 463-466.
40. Loegering, D. A.; Ruchaud, S.; Earnshaw, W. C.; Kaufmann, S. H. Evaluation of the role of caspase-6 in anticancer drug-induced apoptosis. Cell Death Differ. 2006, 13, 346-347.
41. Filomenko, R.; Prevotat, L.; Rebe, C.; Cortier, M.; Jeannin, J.-F.; Solary, E.; Bettaleb, A. Caspase-10 involvement in cytotoxic drug-induced apoptosis of tumor cells. Oncogene 2006, 25, 7635-7645.
42. Johansson, A.-C.; Steen, H.; Ollinger, K.; Roberg, K. Cathepsin D mediates cytochrome c release and caspase activation in human fibroblast apoptosis induced by staurosporine. Cell Death Differ. 2003, 10, 1253-1259.
43. Huo, J. X.; Metz, S. A.; Li, G. D. p53-independent induction of p21(waf1/cip1) contributes to the activation of caspases in GTP-depletion- induced apoptosis of insulin-secreting cells. Cell Death Differ. 2004, 11, 99-109.
44. Deveraux, Q. L.; Takahashi, R.; Salvesen, G. S.; Reed, J. C. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997, 388, 300-304.
45. Klock, R. M.; Bossy-Wetzel, E.; Green, D. R.; Newmeyer, D. D. The release of cytochrome c from mitochondria: a primary site for BcI-2 regulation of apoptosis. Science 1997, 275, 1132-1136.
46. Ricci, J.-E.; Gottlieb, R. A.; Green, D. R. Caspase-mediated loss of mitochondrial function and generation of reactive oxygen species during apoptosis. J. Cell Biol. 2003, 160, 65-75.
47. Ricci, J.-E.; Munoz-Pinedo, C.; Fitzgerald, P.; Bailly-Maitre, B.; Perkins, G. A.; Yadava, N.; Scheffer, I. E.; Ellisman, M. H.; Green, D. R. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 2004, 117, 773-786.